Stay updated on XLRP Clinical Trial: Evaluating Patients with X-linked Retinitis Pigmentosa
Sign up to get notified when there's something new on the XLRP Clinical Trial: Evaluating Patients with X-linked Retinitis Pigmentosa page.

Latest updates to the XLRP Clinical Trial: Evaluating Patients with X-linked Retinitis Pigmentosa page
- Check2 days agoChange DetectedThe footer’s site revision label changes from v3.7.1 to v3.7.2 while the study page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check9 days agoChange DetectedThe ClinicalTrials.gov footer revision changed from v3.7.0 to v3.7.1 while the page continues to display a 403 error.SummaryDifference0.2%

- Check16 days agoChange DetectedThe study record page now shows a 403 Forbidden error with a Home link rather than its prior blank main content area.SummaryDifference0.5%

- Check30 days agoChange DetectedThe page now displays a 403 Forbidden error when attempting to view the study record, indicating restricted access to the resource. This reflects an access-control change rather than an update to the study content.SummaryDifference16%

- Check51 days agoChange DetectedThe page's revision tag was updated from v3.6.5 to v3.6.6, reflecting a minor backend or documentation update without changing study details or functionality.SummaryDifference0.1%

- Check72 days agoChange DetectedThe footer now shows Revision: v3.6.5, replacing v3.6.4, representing a software version update for the page. This change does not modify the study information or available actions on the page.SummaryDifference0.1%

Stay in the know with updates to XLRP Clinical Trial: Evaluating Patients with X-linked Retinitis Pigmentosa
Enter your email address, and we'll notify you when there's something new on the XLRP Clinical Trial: Evaluating Patients with X-linked Retinitis Pigmentosa page.